Depression, Anxiety Clinical Trial
Official title:
An Outreach Collaborative Model for Early Identification and Treatment of Mental Disorder in Danish Workplaces
Depression and anxiety are prevalent mental disorders among the working population with
potentially high personal and financial cost. The aim of the study is to test the
applicability of an outreach collaborative model for early identification and treatment of
clinical and sub-clinical mental disorders among Danish employees. applicability was examined
by I) investigating the fractions of identified and treated clinical and subclinical cases,
II) describing the distribution and characteristics of cases identified and III)
investigating the effect of allocated treatment.
A longitudinal study design with four assessments over 16 months are applied. Six
medium-large companies will be included, both public and private cooperations. Self-reporting
questionnaires probing for psychopathology will be distributed to all employees in the six
consecutively enrolled companies at the four time points. Employees meeting the screening
criteria at T1 will be assessed diagnostically. Subjects diagnosed with a clinical mental
disorder will be allocated to outpatient psychiatric treatment, and subjects with subclinical
conditions will be allocated to preventive cognitive behavioural therapy. Follow-up is
conducted 6 and 12 months after initiation of treatment.
Participation in the study is voluntary at all levels. Written informed consent will be
obtained from participant selected for diagnostic interview and treatment.
BACKGROUND:
Common mental disorders, like depression and anxiety are prevalent mental disorders among the
working population with prevalence's of approximately 3% respectively. These disorder induce
high personal and financial cost, due to increased number of sick days, impaired functioning
- socially and professionally, reduced job satisfaction and reduced quality of life and an
increased risk of loss of work.
In addition to clinical conditions, many employees are affected by symptoms of depression and
anxiety at a subclinical level which can be socially inhibiting for the individual as well as
negatively impacting job satisfaction, work productivity and attendance. Untreated and not
early identified, these subclinical cases can lead to actual mental disorder.
In both the general population and the working population, evidence has demonstrated a high
level of unmet need for mental health care and treatment. The unmet needs are partly
explained by diagnostic difficulties and inadequate treatment in general practice, and partly
by the fact that many individuals affected do not seek professional help.
In light of the high costs and unmet need for treatment, prevention and early detection of
mental disorders among the working population ought to be a public health priority. Evidence
suggests that much could be gained by investing in preventive initiatives.
Research studies within occupational mental health have mainly tested workplace-initiated
stress management programmes or other universal prevention programmes using work-related
outcome measures like sickness absence, work productivity and cost-effectiveness. Secondary
prevention and early intervention programmes targeting mental health problems directly by
using clinical standardized measures of depression or anxiety are limited, or suffer from
limitations such as weak control conditions, short-term follow-up and lack of diagnostic
assessment.
When targeting workplace mental health problems, it is recommended to apply a collaborative
approach between workplaces and mental health specialists in order to minimize the risk of
misclassification and inadequate treatment .
For this study, the investigators therefore developed an outreach secondary prevention model
to be tested in collaboration between the psychiatric treatment system and workplaces in the
North Denmark Region.
AIM:
The overall aim of the study was to investigate the applicability of an outreach
collaborative model for early identification and treatment of clinical and sub-clinical cases
of mental disorder among a Danish working population. The investigation had the following
objectives:
I) To investigate the applicability of the early identification model, measured as fractions
of identified clinical and subclinical cases, fraction of cases who accepted treatment and
fraction of cases who completed treatment II) To describe the distribution and characteristic
of clinical and subclinical cases identified by the early identification model III) To
investigate the effect of allocated treatment on symptomatology for clinical and subclinical
cases
METHOD:
Study design The study applies a longitudinal naturalistic design with four points of
assessment (T0-T3) during a period of 16 months for each participating company. The time from
T0 to T1 (4 months) constitutes a pre-treatment period and is incorporated in the design as a
control period for comparison. After the second assessment (T1), screening and diagnostic
assessment will be initiated. Identified cases will afterwards be allocated to treatment.
Follow-up assessments are conducted after 6 months (T2) and 12 months (T3) for all employees.
The assessments uses self-reporting questionnaires probing for psychopathology. All
questionnaires are mailed to the employees' private postal addresses at the four points of
assessment (T0-T3) followed by a reminder after two weeks in case of no response.
Participants In order to demonstrate the model's applicability in a representative sample,
the investigators will enrol six medium-large companies with a minimum of 100 employees each.
Companies with more than 300 employees will not be addressed due to the limitations of the
available treatment capacity.
Measures The questionnaires used the Symptom Check List 90 Revised (SCL90-R) [30] as basis
for identification of clinical and subclinical cases of mental disorders and follow-up to
treatment. Questionnaires also collected data on demography, different work-related
characteristics and job-satisfaction.
The following screening criteria for identification of clinical and subclinical cases of
mental disorder is used:
i) Global Severity Index score > 0.63 or ii) values of > 0.63 in two or more subscales or
iii) values of > 0.63 in the Depression subscale
Procedure Participants meeting the screening criteria at the second assessment (T1) will be
invited to a diagnostic assessment in order to determine the presence of a mental disorder.
The diagnostic interviews will be conducted by medical doctors at Aalborg Psychiatric
Hospital, all trained and experienced user of the diagnostic instruments utilized. The
presence of a mental disorder will initially be determined by use of Present State
Examination (PSE). Participants assessed with a state of anxiety or depression will
afterwards be rated on the Hamilton Depression Scale (HAM-D) and/or Hamilton Anxiety Scale
(HAM-A) to assess the severity of the condition. Depending on the outcome of the diagnostic
interview, participants will be offered two different courses of treatment:
Treatment course I: Psychiatric treatment for clinical cases Individuals diagnosed with a
mental disorder according to the PSE, and with HAM-D score ≥ 18 or HAM-A score ≥ 20, will be
referred to psychiatric treatment in an outpatient specialized clinic for affective disorders
at Aalborg Psychiatric Hospital. The treatment will follow standard treatment procedures for
psychiatric outpatients with diagnoses of depression and anxiety. Treatment is performed by
trained clinicians (psychiatrists, psychologists and nurses) employed at the Clinic for
Affective Disorders. The course of treatment includes medical consultations as well as
psychotherapeutic sessions and treatment will continue until remission is achieved.
Treatment course II: Preventive treatment for subclinical cases Individuals assessed with
subclinical conditions of depression or anxiety, defined as a HAM-D score of 13-17 or a HAM-A
score of 15-19, are offered preventive treatment. This course of treatment consists of eight
sessions of cognitive behavioral therapy (CBT) conducted by clinical psychologists at Aalborg
Psychiatric Hospital. During the sessions, the therapeutic focus is on stress-reduction and
resilience.
Statistical analysis The primary analysis are carried out by counting the number of clinical
and subclinical cases identified from the early identification procedure. Secondly, the
investigators will perform a descriptive analysis with the study population allocated into
four groups: clinical cases, subclinical cases, untreated cases and healthy subjects. Groups
will be compared at baseline (T1) on demography, work-related characteristics and the three
outcome measures Global Severity Index, Depression and Anxiety.
To analyze the effect of both treatments, the investigators will use mixed effects linear
regression using random intercept and with participants nested inside the companies. A
p-value < 0.05 was considered statistically significant.
Ethics Information about the study are initially provided to the workplace management and the
health and safety representatives and subsequently to all employees at joint open meetings.
It is emphasized that the study is voluntary at all levels. Written participant information
will accompany all questionnaires. The return of the questionnaires will be considered as
acceptance of participation in the questionnaire part. Written informed consent will be
obtained from all participants involved in diagnostic interview and treatment. The employees
are guaranteed complete anonymity in relation to their workplace and company management. The
study are approved by the Danish Data Protection Agency (j. 2008-58-0028). The study was
presented to the Danish Scientific Ethics Committee (N-20070016), but the need for approval
was waived due to the nature of the study.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04122482 -
An Online Course for Improving Knowledge and Access to Mental Health Accommodations in Canadian Enterprises
|
N/A | |
Completed |
NCT04085861 -
Mental Health in Dancers; an Intervention Study
|
N/A | |
Recruiting |
NCT06060210 -
Impact of Ketamine On Depressive Symptoms In Patients Undergoing Lumbo-peritoneal Shunt Insertion
|
Phase 4 | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Recruiting |
NCT06065787 -
NeuroGlove Anxiety and Depression Study
|
N/A | |
Active, not recruiting |
NCT04583891 -
Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design
|
N/A | |
Completed |
NCT05554042 -
Kintsugi Voice Device Study
|
||
Not yet recruiting |
NCT06162624 -
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
|
N/A | |
Not yet recruiting |
NCT06430853 -
Psychobiological Interventions in Pregnancy
|
N/A | |
Completed |
NCT02954250 -
Mindfulness Based Cognitive Therapy for Depression and Cognitive Inhibition in Suicide
|
Early Phase 1 | |
Recruiting |
NCT05647499 -
Evaluating the Back 2 School Program in a Norwegian Setting: A Multicenter Pilot Study
|
N/A | |
Completed |
NCT03980873 -
Cognitive-Behavioral Therapy for Young Adult Lesbian, Gay and Bisexual: Transdiagnostic Minority Stress Approach
|
N/A | |
Completed |
NCT04422327 -
The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome
|
Phase 1/Phase 2 | |
Completed |
NCT05368155 -
Chronic Pelvic Pain and Education Skills Training for Women Veterans
|
N/A | |
Completed |
NCT05455905 -
Voice Biomarkers Predictive of Depression and Anxiety
|
||
Completed |
NCT03272516 -
Mindfulness Based Cognitive Therapy (MBCT) for Primary Care Patients
|
N/A | |
Not yet recruiting |
NCT05493865 -
Parent-Child Single-Session Growth Mindset Intervention on Adolescent Depression and Anxiety Problems
|
N/A | |
Not yet recruiting |
NCT06027047 -
Breakthrough Anxiety and Sleep Evaluation Using Linked Devices and Smartphone Application Onar (BASEL)
|
||
Not yet recruiting |
NCT05535101 -
Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder
|
N/A | |
Recruiting |
NCT04418115 -
Fatigue as a Late Effect in Breast Cancer Survivors - is Acupuncture a Treatment Option?
|
N/A |